Inter Midfielder Arturo Vidal To Undergo Flamengo Medicals Soon With Announcement Expected July 16, Brazilian Media Report

Inter Midfielder Arturo Vidal To Undergo Flamengo Medicals Soon With Announcement Expected July 16, Brazilian Media Report
July 6, 2022 20:30
( )

Inter midfielder Arturo Vidal will fly to Brazil soon where he will undergo his medicals with Flamengo shortly, and an announcement of his official move to the club is expected on July 16.

This according to Brazilian news outlet Lance, who report that the 35-year-old is expected to fly to Rio Di Janeiro this evening for a Copa Libertadores match between Flamengo and Tolima and then will complete his medicals soon.

Everything is all set to go through on a move by Vidal to join Flamengo, and the medicals will be the final remaining piece before he can sign his contract.

The Chilean will be in Brazil shortly, and while he is there the medicals for the move will be one of the main items on his agenda.

Vidal will then return to Italy where he will attend to some personal business, and then he will be back in Brazil where his unveiling as a Flamengo player is expected for later this month.

By Toni Weeler

Inter Striker Romelu Lukaku On Track To Be At His Best For Inter’s Serie A Debut Against Lecce, Italian Media Report

August 1, 2022 17:20
( )

Inter striker Romelu Lukaku appears to be on course to find his best form just in time for the start of the Serie A season.This…

Inter Forward Alexis Sanchez Close To Move To Marseille Whose Sporting Project He’s Convinced By, Italian Media Report

August 1, 2022 17:00
( )

Inter forward Alexis Sanchez looks to be on the verge of choosing Marseille as his club as he feels that they have a suitable sporting…

Italian Journalist Andrea Di Caro: “Inter Better Equipped Than AC Milan To Win The Title But It Will Be A Strange Serie A Season”

August 1, 2022 16:40
( )

Italian journalist Andrea Di Caro believes that Inter go into the Serie A season more likely to win the title than city rivals and defending…

Close

Subscribe

to our newsletter